Explore
Search results
With millions of Americans already infected with COVID-19, public health officials are working to ensure that a safe and effective vaccine is available for every American who wants one. They also want to be sure people aren’t afraid of getting those shots. Nancy Messonnier, M.D., is director of the National Center for Immunization and Respiratory Diseases. She leads the Ce...
Eighteen months after a COVID-19 vaccine became available, high-income countries had administered more than 200 doses per 100 people; in low-income countries, the figure was almost 90 percent less. Access to diagnostics and therapies has been likewise constricted, underscoring the imperative of new approaches to global health equity. Investing in local manufacturing and sc...
Antibodies, convalescent plasma, gene-based vaccines — you may have heard these terms on the evening news, but what do they mean? How might they help in the battle against Covid-19?
While vaccine development was swift to combat COVID-19, just 60% of the global population has been fully immunized and viral variants remain a deadly threat, underscoring the importance of strengthening the “last mile” in vaccination. Ensuring equitable access to vaccines, overcoming structural obstacles to distribution, and combatting vaccine hesitancy will require cross-...
This week marks one year since the first known COVID-19 death. And while the remarkable pace of vaccine development is widely praised, the lag in its distribution is concerning.
An entire generation of children in some of the world’s poorest countries are now protected against deadly infectious diseases, thanks largely to Gavi: The Vaccine Alliance. Impact: more than 16 million lives saved, vast healthcare cost savings, and greater global health security. A leading force behind the push for equitable access to COVID-19 vaccines, Gavi has played a...
More than $2.7 trillion worth of food, medical products, and tobacco, representing 20 percent of every dollar spent by US consumers, is regulated by the Food and Drug Administration (FDA). Always in the public eye, and often summoned to explain its actions to Congress, the FDA is as likely to be lauded as lambasted for its swift authorization of COVID-19 vaccines, its deci...
As scientists work to develop a vaccine to battle the coronavirus pandemic, many people question whether the process has been rushed and if the results will be effective and safe. The U.S. Food and Drug Administration is responsible for approving new vaccines in this country. FDA commissioner Dr. Stephen Hahn and former FDA commissioner Dr. Peggy Hamburg say the agency use...
The coronavirus is mutating rapidly at the same time people around the world are getting vaccinated. Will the vaccines protect us from the variants?
Achieving vaccine equity requires authentically communicating with and listening to all communities. As healthcare leaders, we must go where the community is to hear their stories, comprehend their challenges and better understand how to overcome their hurdles. Presented by Novavax.
Since its founding, the Bill & Melinda Gates Foundation has committed billions of dollars to the search for and distribution of vaccines across the globe. Its knowledge, network, and resources are now being tapped amid the accelerated search for treatments for COVID-19. Gates joins Stephanie Mehta, editor in chief of Fast Company, and shares his expectations for a vaccine...
Seth Berkley, the CEO of GAVI, talks about the importance of vaccines in addressing global health challenges, the role of public-private partnerships in tackling inequities, and new advances in vaccine development.
Anthony Fauci, the nation’s leading infectious disease expert and Director of the National Institute of Allergy and Infectious Diseases, joins CNN Senior Medical Correspondent, Elizabeth Cohen, to discuss the current state of the Covid-19 pandemic and the recent surge in cases as the US reopens. Fauci talks about the US response to the pandemic, including missed opportunit...
Sixty percent of American adults, and 75 percent of children, have been infected with SARS-CoV2. Coupled with immunity-boosting vaccines and medical progress, rates of severe disease, hospitalization, and death are all falling dramatically. Can we declare victory and move on? Or do the threats still facing vulnerable populations require continued precautions? The prospect...
Artificial intelligence isn’t something we’ll see in the future. Thinking machines are already here, and nine powerful companies in the US and China control their development.
Six months into the pandemic, cases are spiking in parts of the country, the death toll continues to rise, and the economy is in shambles. What comes next in this battle?